Search

You searched for "IRD"

150 results found

3rd Annual Retinal Imaging Biomarkers & Endpoints Summit

27 May 2025 -29 May 2025
Accelerate Your Ophthalmic Development with Deep Learning Systems & Sophisticated AI Imaging TechnologiesWith state-of-the-art AI-assisted technology making retinal imaging 100 times faster, the rapid advancement of technology in ophthalmology, coupled with the strong unmet need for more drugs for retinal...

Comparing visual acuity to visual demand levels in classrooms

1 December 2021 | | EYE - Paediatrics, EYE - Strabismus
This study investigated the actual logMAR and contrast sensitivity demands in a cross-sectional sample of kindergarten through grade 12 classrooms in New York city. This was done to consider the potential benefit in optimising the specificity of visual acuity-based screening...

Altomed 2025 MST Malyugin Ring Challenge – Winners Announced!

28 May 2025 | Awards, Conferences & Anniversaries, Company Profiles
Thank you to everyone who stopped by the Altomed stand at the recent RCO Congress and participated in the 2025 #MalyuginRingChallenge. We are pleased to share the final results: Myles Potter. 1st Myles Potter, from Royal Devon and Exeter Hospital,...

Biotech Healthcare Successfully Concludes Global Phakic Users Meeting 2024 in Barcelona

14 October 2024 | Company Profiles, Awards, Conferences & Anniversaries
October 3, 2024 – Celebrating its 25th anniversary, Biotech Healthcare hosted the Global Phakic Users Meeting 2024 at the stunning Joan Miró Foundation in Barcelona on 5th September. Bringing together over 150 ophthalmologists from 28 countries, the event showcased Biotech's...

Single-use Lacrimal probes and punctum dilators

4 May 2023 | Research & Development
Surgitrac® Instruments manufacturers single-use lacrimal probes and dilators.

Litechnica relocate to a new, improved location

24 August 2023 | Research & Development, Company Profiles
Due to increased sales volumes and additional demand for engineering services, Litechnica are excited to announce the relocation of their head office to Hillingdon, Middlesex.

Haag-Streit slit lamps – a fantastic investment for every clinic

21 March 2025 | Research & Development
Haag-Streit slit lamps have earned a legendary reputation for their unmatched quality, precision, clinical reliability, durability, and cost-efficiency. The purchase of a Haag-Streit slit lamp represents a long-term investment in outstanding, future-proof technology. NHS supply chain reference Haag-Streit as the...

Haag-Streit UK announces appointment of Thomas Lenzen as new CEO

2 October 2025 | Company Profiles, Recruitment & Personnel
Haag-Streit UK is pleased to announce the appointment of Thomas Lenzen as the new Chief Executive Officer (CEO) of the Haag-Streit Group. Thomas Lenzen. With more than two decades of international leadership experience in the med tech industry, Thomas Lenzen...

Early bird bookings are open for Optometry Tomorrow 2024 – now incorporating BCLA Focus

20 September 2023 | BCLA, College of Optometrists, optometry, CPD
Taking place from 28-29 April 2024, at the Telford International Centre, the flagship conference of The College of Optometrists now incorporates the biennial UK conference of the British Contact Lens Association.

The Eyes on Tomorrow Podcast

12 July 2024 | podcast, media, interview, conversation, eyes on tomorrow
So why would an ophthalmologist and an optometrist want to do a podcast together?

United Kingdom and Eire Glaucoma Society (UKEGS) Conference: Last chance for Early Bird tickets!

10 July 2024 | UKEGS, events, conference, congress, early bird, glaucoma, glaucoma uk, diary, Nishani Amerasinghe, Anthony King, Andrew Tatham
The United Kingdom and Eire Glaucoma Society (UKEGS) invites you to its annual conference, hosted by Consultant Ophthalmologist Nishani Amerasinghe, on 9 and 10 October 2024 at the National Oceanography Centre in Southampton.

Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service

3 April 2023 | | EYE - General
Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...